Lonza Group reported CHF1.79B in Cost of Sales for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Akzo Nobel AKZA:NA EUR 1.88B 64M
Alcon AG ALC:SW USD 972M 6M
AstraZeneca AZN:LN USD 2.12B 214M
Bayer BAYN:GR EUR 4.25B 1.43B
Covestro 1COV:GR EUR 4.06B 275M
Fresenius FRE:GR EUR 7.75B 414M
Fresenius Medical Care FME:GR EUR 3.74B 326.58M
Givaudan GIVN:VX CHF 2.19B 257M
GlaxoSmithKline GSK:LN GBP 2.18B 209M
GN Store Nord GN:DC DKK 2.35B 31M
Hikma Pharmaceutical HIK:LN USD 590M 62M
Johnson Matthey JMAT:LN GBP 6.84B 92M
Merck MRK:GR EUR 2.15B 38M
Novartis NOVN:VX USD 3.66B 92M
Philips PHIA:NA EUR 3.2B 621M
Roche Holding ROG:VX 9.56B 717M
Smith & Nephew PLC SN/:LN 773M 36M
Solvay SOLB:BB EUR 3.3B 302M
William Demant Holding WDH:DC DKK 2.41B 134M